Skip to main content

Exact Sciences to Participate in September Investor Conferences

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conferences and invited investors to participate by webcast.

  • Wells Fargo Healthcare Conference, Boston

    Fireside chat on Wednesday, September 4, 2024 at 3:45 p.m. ET

  • Baird Global Healthcare Conference, New York

    Fireside chat on Wednesday, September 11, 2024 at 10:15 a.m. ET

The webcasts can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X (formerly known as Twitter) @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  235.43
+1.55 (0.66%)
AAPL  284.85
+1.75 (0.62%)
AMD  222.59
+2.83 (1.29%)
BAC  53.51
+0.27 (0.50%)
GOOG  317.72
+2.60 (0.83%)
META  642.68
+1.81 (0.28%)
MSFT  490.63
+3.89 (0.80%)
NVDA  183.82
+3.91 (2.17%)
ORCL  206.85
+5.91 (2.94%)
TSLA  433.26
+3.12 (0.73%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.